EcoDrugPlus

Complement C5-Like

Ensembl ID : ENSMOCG00000021554
Gene Symbol: LOC101988201
3 Cross references
199 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSMOCG00000012063
Gene Symbol: CFD
3 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMOCG00000011532
Gene Symbol: CRHR1
3 Cross references
240 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMOCG00000013593
Gene Symbol: CCND1
3 Cross references
277 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSMOCG00000021938
Gene Symbol: CDK1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSMOCG00000005645
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSMOCG00000008699
Gene Symbol: CDK4
2 Cross references
209 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSMOCG00000020337
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSMOCG00000000083
Gene Symbol: CDK6
3 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSMOCG00000001992
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSMOCG00000022103
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMOCG00000001518
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).